NAUTILUS BIOTECHNOLOGY INC (NAUT:NASDAQ)
$2.24 -0.045 (-1.9694%)
Analysed NAUTILUS BIOTECHNOLOGY INC (NAUT:NASDAQ) News Sources
Nautilus Biotechnology Unveils Voyager Proteomics Platform, Targets Beta Access in 2H and Launch Next Year
25-03-2026
marketbeat.com
Q1 Virtual Investor Summit Presentations Now Available On Demand
26-03-2026
yahoo.com
Nautilus Biotechnology to Announce First Quarter 2026 Financial Results on April 28, 2026
09-04-2026
yahoo.com
Here is Why Nautilus Biotechnology (NAUT) is One of the Best Life Sciences Penny Stocks to Buy
14-04-2026
yahoo.com
Nautilus Biotechnology Reports First Quarter 2026 Financial Results
28-04-2026
yahoo.com
Nautilus Biotechnology Q1 Earnings Call Highlights
28-04-2026
marketbeat.com
Nautilus Biotechnology Inc (NAUT) Q1 2026 Earnings Call Highlights: Strategic Advances Amid ...
29-04-2026
yahoo.com
Nautilus Biotechnology (NASDAQ:NAUT) Is In A Good Position To Deliver On Growth Plans
05-05-2026
yahoo.com
3 Promising Penny Stocks With Market Caps Up To $900M
05-05-2026
yahoo.com
3 Penny Stocks With Market Caps Over $100M To Watch
03-06-2026
yahoo.com
What is the current price of NAUTILUS BIOTECHNOLOGY INC (NAUT:NASDAQ)?
The current price of NAUTILUS BIOTECHNOLOGY INC (NAUT:NASDAQ) is $2.24.
NAUTILUS BIOTECHNOLOGY INC (NAUT:NASDAQ) absolute price change since previous trading day?
The absolute price change of NAUTILUS BIOTECHNOLOGY INC (NAUT:NASDAQ) since the previous trading day is $-0.045.
NAUTILUS BIOTECHNOLOGY INC (NAUT:NASDAQ) percentage price change since previous trading day?
The percentage price change of NAUTILUS BIOTECHNOLOGY INC (NAUT:NASDAQ) since the previous trading day is -1.9694%.
What is the most recent average sentiment score for NAUTILUS BIOTECHNOLOGY INC (NAUT:NASDAQ)?
The most recent average sentiment score for NAUTILUS BIOTECHNOLOGY INC (NAUT:NASDAQ) is 83 out of 100.
What is the most recent average sentiment for NAUTILUS BIOTECHNOLOGY INC (NAUT:NASDAQ)?
The most recent sentiment for NAUTILUS BIOTECHNOLOGY INC (NAUT:NASDAQ) is .
SEC-8K** Filing Available For NAUTILUS BIOTECHNOLOGY INC (NAUT:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.